Chewy, Inc. — Form 10-Q Summary
Reporting period: The filing covers the 13 weeks ended April 30, 2023, compared with the 13 weeks ended May 1, 2022. The request metadata says “2022 Q1,” but the filing itself is for 2023 Q1.
Business context and financial results
Chewy operates an e-commerce business selling pet products and services. It reported net sales of $2.785 billion, up 14.7% year over year, with growth attributed primarily to higher spending per customer. Consumables sales rose 18.0%, other sales rose 13.3%, and hardgoods sales declined 1.6%.
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Gross profit / gross margin | $791.5 million / 28.4% | $667.8 million / 27.5% |
| Operating income / margin | $24.1 million / 0.9% | $18.8 million / 0.8% |
| Net income / net margin | $22.2 million / 0.8% | $18.5 million / 0.8% |
| Adjusted EBITDA / margin | $110.2 million / 4.0% | $60.5 million / 2.5% |
| Operating cash flow | $148.4 million | $82.4 million |
| Capital expenditures | $21.6 million | $76.0 million |
| Free cash flow | $126.8 million | $6.4 million |
Basic and diluted GAAP earnings per share were $0.05, versus $0.04. Adjusted net income was $87.2 million and adjusted diluted EPS was $0.20; these are non-GAAP measures. Share-based compensation and related taxes were $53.8 million, compared with $27.2 million.
Liquidity, debt, and cash flow
At April 30, 2023, cash and cash equivalents were $408.7 million and marketable securities were $394.5 million. The company reported $1.734 billion in current assets and $1.893 billion in current liabilities. It had no borrowings under its $800 million asset-based revolving credit facility and reported $749.6 million of borrowing capacity, subject to the borrowing base. The facility matures August 27, 2026.
Cash increased $78.2 million during the quarter. Operating cash flow improved year over year, supported in part by higher payables and other current liabilities; inventory and receivables were cash uses. Investing cash flow included net purchases of marketable securities and capital spending, principally for fulfillment capacity and technology.
Material changes and management commentary
- Gross margin expanded 90 basis points, which management attributed to pricing strength, favorable sales mix, supply-chain efficiencies, and margin expansion in consumables, healthcare, and specialty businesses.
- Net sales per active customer rose 14.8% to $512, while active customers decreased 0.9% to 20.419 million. Autoship customer sales increased 18.6% to $2.081 billion and represented 74.7% of net sales, up from 72.2%.
- Advertising and marketing expense rose 27.0% to $183.7 million, reflecting increased investment in upper-funnel and new marketing channels. SG&A rose 15.7% to $583.7 million, including higher facilities, fulfillment, and share-based compensation costs.
- Management said inflation, higher interest rates, and changing consumer behavior continue to affect the business; the duration and ultimate impact remain uncertain. It believes available cash, marketable securities, and credit capacity will cover working capital, capital expenditures, and contractual obligations for at least the next 12 months.
Outlook, risks, and unusual items
The filing provides no quantitative revenue or earnings guidance. It cautions that quarterly results are not necessarily indicative of full-year performance and that forward-looking statements are subject to substantial risks, including competition, customer acquisition and retention, supply-chain and fulfillment execution, macroeconomic conditions, cybersecurity, and the ability to manage growth and maintain profitability.
Other expense was $8.9 million, primarily from an $8.9 million decline in the fair value of equity warrants. The Petabyte acquisition purchase-price allocation remained preliminary; the acquisition was not material to reported results. IBM is appealing prior rulings favorable to Chewy and, following reexamination of a patent, asserted a new infringement allegation; Chewy disputes the allegations and intends to defend itself. Management said it did not expect currently pending legal matters to have a material adverse effect, while noting outcomes are uncertain.
The company reported effective disclosure controls as of April 30, 2023, no material changes in internal control over financial reporting during the quarter, and no material changes to the risk factors in its latest Form 10-K.
Important facts for investors to verify
- Confirm the period: this filing is for the quarter ended April 30, 2023, not 2022 Q1.
- Assess whether sales growth and higher spend per customer can persist alongside the slight decline in active customers.
- Review the quality and sustainability of margin and free-cash-flow improvement, including working-capital timing and the large increase in share-based compensation.
- Monitor the valuation and assumptions for Level 3 equity warrants, and the status and potential exposure of the IBM litigation.
- Track macroeconomic impacts, fulfillment and capital-investment needs, and the availability of borrowing capacity under the borrowing-base-dependent credit facility.